Panobacumab
Panobacumab
Panobacumab (pronounced: pano-bac-u-mab) is a monoclonal antibody designed for the treatment of infections caused by the bacterium Pseudomonas aeruginosa.
Etymology
The term "Panobacumab" is derived from the combination of Pano (short for Pseudomonas), bac (indicating its bacterial target), and umab (a suffix used in the nomenclature of monoclonal antibodies).
Function
Panobacumab works by binding to the lipopolysaccharide (LPS) present on the outer membrane of Pseudomonas aeruginosa, thereby neutralizing the bacterium and preventing it from causing infection.
Related Terms
- Monoclonal Antibody: A type of protein made in the laboratory that can bind to substances in the body, including bacteria. Panobacumab is a type of monoclonal antibody.
- Pseudomonas aeruginosa: A common bacterium that can cause disease in animals, including humans. It is the target of Panobacumab.
- Lipopolysaccharide: A large molecule consisting of a lipid and a polysaccharide joined by a covalent bond; found in the outer membrane of Gram-negative bacteria, such as Pseudomonas aeruginosa.
External links
- Medical encyclopedia article on Panobacumab
- Wikipedia's article - Panobacumab
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski